Davis R M Inc
- SEC CIK
- 0000891287
- Latest filing
- Aug 14, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by Davis R M Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q2 2026)
- 122,380
- Value
- $61.4M
- % of portfolio
- 1.0%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 122,380 | $61.4M | 1.0% | −612−0.5% | Reduced | Holders |
| Q1 2026 | 122,992 | $60.5M | 1.1% | −1,139−0.9% | Reduced | Holders |
| Q4 2025 | 124,131 | $71.9M | 1.2% | −1,748−1.4% | Reduced | Holders |
| Q3 2025 | 125,879 | $61.1M | 1.1% | −2,494−1.9% | Reduced | Holders |
| Q2 2025 | 128,373 | $52.1M | 1.0% | −1,322−1.0% | Reduced | Holders |
| Q1 2025 | 129,695 | $64.5M | 1.3% | −1,380−1.1% | Reduced | Holders |
| Q4 2024 | 131,075 | $68.2M | 1.3% | −818−0.6% | Reduced | Holders |
| Q3 2024 | 131,893 | $81.6M | 1.6% | +4,225+3.3% | Added | Holders |
| Q2 2024 | 127,668 | $70.6M | 1.4% | −2,688−2.1% | Reduced | Holders |
| Q1 2024 | 130,356 | $75.8M | 1.6% | −606−0.5% | Reduced | Holders |
| Q4 2023 | 130,962 | $69.5M | 1.6% | −7,341−5.3% | Reduced | Holders |
| Q3 2023 | 138,303 | $70.0M | 1.8% | −3,678−2.6% | Reduced | Holders |
| Q2 2023 | 141,981 | $74.1M | 1.8% | −1,772−1.2% | Reduced | Holders |
| Q1 2023 | 143,753 | $82.9M | 2.1% | −886−0.6% | Reduced | Holders |
| Q4 2022 | 144,639 | $79.7M | 2.1% | +670.0% | Added | Holders |
| Q3 2022 | 144,572 | $73.3M | 2.1% | −155−0.1% | Reduced | Holders |
| Q2 2022 | 144,727 | $78.6M | 2.2% | +763+0.5% | Added | Holders |
| Q1 2022 | 143,964 | $85.0M | 2.0% | +194+0.1% | Added | Holders |
| Q4 2021 | 143,770 | $95.9M | 2.1% | −711−0.5% | Reduced | Holders |
| Q3 2021 | 144,481 | $82.5M | 2.0% | +135+0.1% | Added | Holders |
| Q2 2021 | 144,346 | $72.8M | 1.8% | +440+0.3% | Added | Holders |
| Q1 2021 | 143,906 | $65.7M | 1.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.